Challenges of antibiotic discovery: Antibiotic resistance and tolerance plus troubles with discovery platforms complicate efforts to identify useful antibacterial drug candidates

Microbe

Volumn 10, Issue 9, 2015, Pages 363-369

  Lewis, Kim ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942246998     PISSN: 15587452     EISSN: 15587460     Source Type: Journal    
DOI: 10.1128/microbe.10.363.1     Document Type: Article

References (10)

1. Conlon, B. P., E. S. Nakayasu, L. E. Fleck, M. D. LaFleur, V. M. Isabella, K. Coleman, S. N. Leonard, R. D. Smith, J. N. Adkins, and K. Lewis. 2013. Activated ClpP kills persisters and eradicates a chronic biofılm infection. Nature 503:365–370.
2. Gavrish, E., C. S. Sit, S. Cao, O. Kandror, A. Spoering, A. Peoples, L. Ling, A. Fetterman, D. Hughes, A. Bissell, H. Torrey, T. Akopian, A. Mueller, S. Epstein, A. Goldberg, J. Clardy, and K. Lewis. 2014. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 21: 509–518.
3. Hernandez, V., T. Crepin, A. Palencia, S. Cusack, T. Akama, S. J. Baker, W. Bu, L. Feng, Y. R. Freund, L. Liu, M. Meewan, M. Mohan, W. Mao, F. L. Rock, H. Sexton, A. Sheoran, Y. Zhang, Y. K. Zhang, Y. Zhou, J. A. Nieman, M. R. Anugula, E. M. Keramane, K. Savariraj, D. S. Reddy, R. Sharma, R. Subedi, R. Singh, A. O’Leary, N. L. Simon, P. L. De Marsh, S. Mushtaq, M. Warner, D. M. Livermore, M. R. Alley, and J. J. Plattner. 2013. Discovery of a novel class of boron-based antibacterials with activity against gramnegative bacteria. Antimicrob. Agents Chemother. 57: 1394–1403.
4. Lewis, K. 2013. Platforms for antibiotic discovery. Nature Rev. Drug Discov. 12:371–387.
5. Ling, L. L. T. Schneider, A. J. Peoples, I. E. Spoering, B. P. Conlon, D. E. Hughes, S. Epstein, M. Jones, L. Lazarides, V. Steadman, D. R. Cohen, C. R. Felix, K. A. Fetterman, B. P. Millet, A. G. Nitti, A. M. Zullo, C. Chen, and K. Lewis. 2015.Anovel antibiotic kills pathogens without detectable resistance. Nature 517: 455–459.
6. Payne, D. J., M. N. Gwynn, D. J. Holmes, and D. L. Pompliano. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Rev. Drug Discov. 6:29–40.
7. Pucci, M. J., and K. Bush. 2013. Investigational antimicrobial agents of 2013. Clin. Microbiol. Rev. 26: 792–821.
8. Srinivas, N., P. Jetter, B. J. Ueberbacher, M. Werneburg, K. Zerbe, J. Steinmann, B. Van der Meijden, F. Bernardini, A. Lederer, R. L. Dias, P. E. Misson, H. Henze, J. Zumbrunn, F. O. Gombert, D. Obrecht, P. Hunziker, S. Schauer, U. Ziegler, A. Kach, L. Eberl, K. Riedel, S. J. DeMarco, and J. A. Robinson. 2010. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327:1010–1013.
9. Starkey, M., F. Lepine, D. Maura, A. Bandyopadhaya, B. Lesic, J. He, T. Kitao, V. Righi, S. Milot, A. Tzika, and L. Rahme. 2014. Identifıcation of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. PLoS Pathog. 10: e1004321.
10. Wilson, M. C., T. Mori, C. Ruckert, A. R. Uria, M. J. Helf, K. Takada, C. Gernert, U. A. Steffens, N. Heycke, S. Schmitt, C. Rinke, E. J. Helfrich, A. O. Brachmann, C. Gurgui, T. Wakimoto, M. Kracht, M. Crusemann, U. Hentschel, I. Abe, S. Matsunaga, J. Kalinowski, H. Takeyama, and J. Piel. 2014. An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature 506:58–62.